Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Other Expenses

v3.22.0.1
Other Expenses
12 Months Ended
Dec. 31, 2021
Analysis of income and expense [abstract]  
Other Expenses Other Expenses
The following details highlight certain components of the research and development and operating expenses classified by nature. The foreign exchange loss as presented separately on the face of the consolidated statement of loss and comprehensive loss is also classified as a research and development expense. Remaining research and development and operating expenses include expenses paid to third parties.
For the years ended December 31, 2021 2020 2019
Included in research and development expenses:
Employee compensation and benefits $ 4,645,264  $ 3,775,263  $ 3,096,231 
Share-based compensation 2,086,608  1,043,373  561,420 
Included in operating expenses
Depreciation - property and equipment $ 130,243  $ 88,957  $ 122,982 
Depreciation - right-of-use assets 321,822  357,230  362,592 
Employee compensation and benefits 2,542,210  2,635,170  2,555,274 
Share-based compensation 1,739,293  1,515,601  908,733 
Transaction cost, warrant derivative   —  233,143